During the past decade, UCLA Department of Urology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UCLA Department of Urology" are "Bladder Cancer" (1 trials), "Non-muscle Invasive Bladder Cancer" (1 trials), "Pharmacokinetics" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "UCLA Department of Urology" in a lesser frequency.

Most popular intervention types in "UCLA Department of Urology" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "BCG" (1 trials), "BCG in Combination with N-803" (1 trials), "BCG+N-803" (1 trials), "N-803" (1 trials) and "N-803 alone" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Department of Urology" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "UCLA Department of Urology". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UCLA Department of Urology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Department of Urology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".